2010
DOI: 10.1053/j.seminoncol.2010.06.013
|View full text |Cite
|
Sign up to set email alerts
|

Mucinous Adenocarcinoma of the Ovary

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2011
2011
2023
2023

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 21 publications
0
2
0
Order By: Relevance
“…In their series, FOLFOX was used only for mucinous histologies; therefore, the role of FOLFOX in treating other histologic subtypes of malignancy arising from an MCT remains unknown; thus, further research is warranted. FOLFOX-4 has shown activity in platinum/taxane-resistant heavily pretreated ovarian cancers across serous, mucinous, endometrioid, clear cell, and undifferentiated histologies [ 36 37 38 ].…”
Section: Discussionmentioning
confidence: 99%
“…In their series, FOLFOX was used only for mucinous histologies; therefore, the role of FOLFOX in treating other histologic subtypes of malignancy arising from an MCT remains unknown; thus, further research is warranted. FOLFOX-4 has shown activity in platinum/taxane-resistant heavily pretreated ovarian cancers across serous, mucinous, endometrioid, clear cell, and undifferentiated histologies [ 36 37 38 ].…”
Section: Discussionmentioning
confidence: 99%
“…Other studies have later confirmed this relationship. 5 Mucinous ovarian cancers are diagnosed at Stage I in 83%of the cases and only 17% are Stage II or above. Meanwhile Serous ovarian carcinomas 4 % of patients are diagnosed at Stage I and 96 % are stage II or above at the time of diagnosis.…”
Section: Discussionmentioning
confidence: 99%